Conexiant

What is Conexiant? At Conexiant, we drive growth with tailored strategies and data-driven solutions. Trusted by 60% of U.S. News Top Hospitals, we connect over 2.8 million healthcare professionals through 35+ publications. Watch this video to learn how we’re shaping the future of healthcare and unlocking new opportunities for businesses. Learn more about us here ?? go.conexiant.com/solutions #HealthcareMarketing #HealthcareInnovation #MedicalInsights #Conexiant #DigitalHealthcare

A study of over 120,000 adults found that daily screen use before bed is linked to poorer sleep quality and shorter sleep duration. Those with evening chronotypes experienced more significant disruptions, with later bedtimes and up to 50 minutes less sleep per week. These findings highlight the impact of screen time on adult sleep and the need for strategies to improve sleep hygiene, especially for those at risk. Learn more: https://lnkd.in/eaGaHJsn #SleepHealth #Chronotype

65% of U.S. News & World Report Honor Roll Hospitals and many leading Medical Device brands trust Conexiant’s omnichannel strategies to connect meaningfully with healthcare professionals, drive referrals, enhance reputation, and deliver measurable results. ? For over 25 years, Conexiant has paired trusted KOL-led content with their industry leading physician engagement solutions to create a seamless messaging journey with measurable touchpoints that drive adoption, engagement, and conversions. ? Want to see how Conexiant can elevate your brand? Learn more here: conexiantsolutions.com ? Connect with our experts, Michael Ciaburri and Scott Clelland, to explore how a tailored omnichannel strategy, powered by proprietary user-level data, can deliver meaningful ROI for your business. ? Ready to take the next step? Skip the wait and book a meeting today: go.conexiant.com/meet-mike

Why work with Conexiant Oncology? We represent the most trusted oncology publications and exclusive HCP engagement platforms, including: ? JADPRO: The official journal of APSHO, serving oncology NPs, PAs, and PharmDs? ? JNCCN: The only publication featuring NCCN Clinical Practice Guidelines? ? The ASCO Post & JCO: Leading ASCO-affiliated oncology news & research? ? APSHO & JADPRO Live: Bringing oncology APs and industry together Work with us to put your brand where oncology decision-makers turn for education.?Learn more about our network here: go.conexiant.com/oncology

A recent meta-analysis has identified potential associations between certain dietary factors and a reduction in tinnitus prevalence. The study highlights four key dietary components—fruit, dietary fiber, caffeine, and dairy—showing promise in potentially reducing the incidence of this common and distressing condition. While tinnitus affects approximately 14% of adults globally, current treatment options remain varied and often inconsistent. These findings offer a glimpse into how lifestyle interventions, particularly diet, could play a role in managing tinnitus. The research suggests that dietary fiber may improve insulin sensitivity, while fruit and dairy could enhance blood vessel function. Caffeine's potential benefits are also worth noting, particularly regarding its impact on nerve function. The results indicate a need for further large-scale studies to verify these associations and better understand their therapeutic potential. Explore more about how dietary adjustments could contribute to managing tinnitus: https://lnkd.in/ev3szBud #TinnitusManagement #DietAndHealth #ClinicalResearch

A recent study showed that a Top 10 U.S. News & World Report hospital increased its website traffic from 80k to 300k just by partnering with Conexiant. ? Trusted by 13 of the top 20 U.S. News Honor Roll hospitals, Conexiant helps healthcare institutions reach new patients and referring providers through targeted digital strategies. We continuously optimize campaigns to deliver meaningful results—not just vanity metrics. Our focus is on connecting hospitals with the right audiences to drive patient acquisition and referrals. ? Get instant access to a free 6-page guide to optimize your hospital's reputation and also learn how Conexiant can help you climb the ranks here: go.conexiant.com/hospitals Ready to connect and learn how our tailored solutions can fit your specific needs? Reach out to Michael Ciaburri directly, or skip the wait and schedule a time that works for you here: go.conexiant.com/meet-mike

Check out Conexiant Oncology's new home! Visit go.conexiant.com/oncology to discover how we’re helping oncology brands connect with over 95,000 engaged oncologists through targeted marketing solutions. Our exclusive partnerships and innovative offerings in advertising, content creation, brand awareness, and events are designed to drive measurable results. Oncologists trust our content for clinical education and insights—let us show you how we can do the same for your brand. Ready to see the impact? Visit our new page and click get started to talk to the team today! #OncologyMarketing #HealthcareMarketing #BrandEngagement #ClinicalEducation #OncologyProfessionals #ContentCreation #ConexiantOncology

Join us at the 50th Annual ONS Congress? in Denver, CO, from April 9th–13th! Conexiant Oncology is proud to be part of this landmark year, and we’re excited to showcase our work at such a significant event. ? If you’d like to connect with the team, Lauren?Morgan?will be there representing JADPRO. You can reserve time with them by booking directly here: go.conexiant.com/lauren, or by visiting the team at booth #5066?. ? Want to learn more about how Conexiant Oncology helps brands connect with over 95,000 engaged oncologists through targeted advertising, custom content, event partnerships, and more? Visit here: go.conexiant.com/oncology ? See you in Denver! ? #ONS2025 #Oncology #JADPRO #ConexiantOncology #ONS #OncologyNursing #HealthcareEvents

A recent cohort study involving over 13,000 patients found no increased risk of major adverse cardiovascular events (MACE) associated with nicotinamide use, a form of vitamin B3 commonly used in skin cancer prevention. The findings suggest that nicotinamide remains a safe option for patients at high risk for skin cancer, including organ transplant recipients. For clinicians, these results offer reassurance in recommending nicotinamide for chemoprevention without concerns of adverse cardiovascular outcomes. #CardiovascularRisk #Nicotinamide

Conexiant is proud to partner with Elsevier, bringing together two industry leaders in healthcare intelligence and education to support over 100 of the world’s leading medical societies and associations. This collaboration amplifies our mission to empower healthcare professionals with the most trusted clinical content, cutting-edge educational resources, and actionable insights to drive better patient outcomes. For societies and associations, this means expanded opportunities to enhance member engagement, generate new revenue streams, and strengthen their role as a vital source of medical knowledge. Through this partnership, we’re expanding access to unparalleled medical expertise, advanced digital learning, and innovative engagement solutions by connecting 2.8M+ HCPs with the knowledge they need to excel. Together, we’re shaping the future of healthcare learning and engagement. Stay tuned for more! go.conexiant.com/pr #Conexiant #Elsevier #HealthcareEducation #MedicalInnovation #HCPEngagement?